NCT02261987

Brief Summary

This trial aims to analyze whether the resistive inspiratory manoeuvre (RIM) performed previously to autogenic drainage (AD) technique improves the effectiveness in terms of mucus clearance during a typical bronchial drainage session in adults, stable CF patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 7, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 10, 2014

Completed
22 days until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

November 15, 2016

Status Verified

November 1, 2016

Enrollment Period

1.5 years

First QC Date

October 7, 2014

Last Update Submit

November 11, 2016

Conditions

Keywords

Autogenic drainageResistive inspiratory manoeuvreComputerized respiratory soundsAirway clearance techniquesMucus clearances

Outcome Measures

Primary Outcomes (1)

  • Wet sputum production

    24h wet sputum production (g) after bronchial drainage session

    24 hours

Secondary Outcomes (4)

  • Wet sputum production

    30 minutes

  • Computerized respiratory sounds

    30 minutes

  • Lung function (simply spirometry)

    30 minutes

  • Patients´ perception

    30 minutes

Other Outcomes (1)

  • Pulse-oximetry, heart rate and dyspnea

    30 minutes

Study Arms (3)

Autogenic drainage (AD)

ACTIVE COMPARATOR

Patients will perform the autogenic drainage technique following the Chevallier and Agostini recommendations.

Other: Autogenic drainage (AD)

Resistive inspiratory manoeuvre (RIM)

ACTIVE COMPARATOR

Patients will perform the repetitive inspiratory manoeuvers by breathing through a fixed resistance (Power Breathe device, model KH1) . Each session will comprise to cycles of 5 inspiratory breaths (60% of maximal inspiratory pressure). Patients will be stay in both lateral decubitus position (15 min per side).

Other: Resistive inspiratory manoeuvre (RIM)

Resistive inspiratory manoeuvre+autogenic drainage

ACTIVE COMPARATOR

First, patients will perform the resistive inspiratory manoeuvre during 10 minutes (5 min per side). Right after, patients will perform the autogenic drainage during 20 minutes.The instructions will be similar to described previously.

Other: Resistive inspiratory manoeuvre+autogenic drainage

Interventions

It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.

Autogenic drainage (AD)

It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.

Resistive inspiratory manoeuvre (RIM)

It will be apply in one only session. The time spent during this bronchial drainage session will be 30 minutes All patients will perform all interventions in a randomized order.

Resistive inspiratory manoeuvre+autogenic drainage

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Cystic Fibrosis (CF) diagnosed ( established by genotype or sweat sodium\>70 mmol/l or sweat chloride of\>60 mmol/l)
  • Clinically stable at time of study entry (defined as no requirement for antibiotics or change in respiratory medication in the preceding 4 wk);
  • Chronic sputum production, at least ≥ 15 ml /24h
  • Familiar and trained in the use of autogenic drainage technique (at least 6 months) and resistive inspiratory manoeuvre (at least three previous sessions)
  • To be able to provide written, informed consent

You may not qualify if:

  • Lung function: Forced expiratory volume in 1 second \< 30 % pred . ; Forced vital capacity \< 40 % pred.
  • Active haemoptysis during the previous month
  • Supplemental oxygen or non-invasive ventilation (NIV)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Cystic Fibrosis Association

Madrid, Madrid, Spain

Location

Cystic Fibrosis Association

Murcia, Murcia, Spain

Location

Cystic Fibrosis Association

Valencia, Valencia, Spain

Location

Universidad San Jorge

Zaragoza, Zaragoza, 50830, Spain

Location

Related Publications (1)

  • Chatham K, Ionescu AA, Nixon LS, Shale DJ. A short-term comparison of two methods of sputum expectoration in cystic fibrosis. Eur Respir J. 2004 Mar;23(3):435-9. doi: 10.1183/09031936.04.00084904.

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Officials

  • Beatriz Herrero, Msc

    Universidad San Jorge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 7, 2014

First Posted

October 10, 2014

Study Start

November 1, 2014

Primary Completion

May 1, 2016

Study Completion

June 1, 2016

Last Updated

November 15, 2016

Record last verified: 2016-11

Locations